CLINIMIX E 290 mg/100mL

CLINIMIX E 290 mg/100mL is an intravenous injection containing essential amino acids. It is designed to support nutritional needs in clinical settings, providing a balanced blend of leucine, phenylalanine, lysine, methionine, isoleucine, valine, histidine, threonine, tryptophan, and alanine. This product is manufactured by Baxter Healthcare Company in the USA.

CLINIMIX E 290 mg/100mL is primarily used to provide essential amino acids to patients who cannot meet their nutritional needs through oral intake. It is often administered intravenously to support protein synthesis and overall nutritional status. This injection is commonly used in clinical settings where patients require nutritional support due to various medical conditions.

The effects of CLINIMIX E 290 mg/100mL are generally related to its role in providing essential amino acids. Patients may experience improved nutritional status and support for protein synthesis. As with any medical product, individual responses can vary, and it is important to follow the advice of a healthcare professional.

CLINIMIX E 290 mg/100mL should be handled with care and administered under the supervision of a healthcare professional. It is important to follow proper storage and handling guidelines to ensure the product's efficacy and safety. Patients with known allergies to any of the components should avoid using this product.

CLINIMIX E 290 mg/100mL may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult with a healthcare professional before starting any new treatment.